CONSENSUS STATEMENT Advanced Parkinson ’ s disease : Clinical characteristics and treatment ( part 1 )
نویسندگان
چکیده
a Servicio de Neurología, Hospital Sant Pau, IIB Sant Pau, CIBERNED, Universitat Autònoma de Barcelona, Barcelona, Spain b Servicio de Neurología, Clinica Universidad de Navarra, Pamplona, Spain c Servicio de Neurología, Hospital Universitario Insular de Gran Canaria, Gran Canaria, Spain d Servicio de Neurología, Hospital La Fe, Valencia, Spain e Servicio de Neurología, Hospital Universitario Virgen del Rocío, Sevilla, Spain f Servicio de Neurología, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain g Servicio de Neurología, Hospital Infanta Luisa, Sevilla, Spain h Servicio de Neurología, Fundación Jiménez Díaz, Madrid, Spain i Servicio de Neurología, Hospital de Cruces, Bilbao, Spain j Servicio de Neurología, Hospital Ramón y Cajal, Madrid, Spain k Servicio de Neurología, Hospital del Mar, Barcelona, Spain l Servicio de Neurología, Hospital Clínic, IDIBAPS, CIBERNED, Barcelona, Spain m Servicio de Neurología, Complejo Hospitalario Universitario, Ourense, Spain
منابع مشابه
P 48: Pioglitazone in Early Parkinson: A Review Study
More than 10 million people worldwide are living with Parkinson’s disease (PD). The ages of people who have Parkinson are variable, usually between 50 and 80 years, the average of them is 55 years old. The symptoms of PD are progressive, and within 10 to 20. It happens when dopaminergic neurons were being degenerate. Peripheral and central inflammatory and oxidative stress pathways play a...
متن کاملP 105: The Role of LRRK2 Inhibitors in Treatment of Parkinson’s Disease
Parkinson’s disease is the second most common age associated neuron degenerative disorder in developed societies. With the prevalence ranging from 41 per 100000 in the fourth decade of life to over 1900 per 100000 in people over 80 years of age.it characterized clinically by resting tremor, slowness of movement, rigidity and postural instability in the result of progressive loss of dopami...
متن کامل[Advanced Parkinson's disease: clinical characteristics and treatment (part 1)].
INTRODUCTION A large percentage of patients with Parkinson's disease (PD) develop motor fluctuations, dyskinesias, and severe non-motor symptoms within 3 to 5 years of starting dopaminergic therapy, and these motor complications are refractory to treatment. Several authors refer to this stage of the disease as advanced Parkinson's disease. OBJECTIVE To define the clinical manifestations of ad...
متن کاملGait Based Vertical Ground Reaction Force Analysis for Parkinson’s Disease Diagnosis Using Self Organizing Map
The aim of this work is to use Self Organizing Map (SOM) for clustering of locomotion kinetic characteristics in normal and Parkinson’s disease. The classification and analysis of the kinematic characteristics of human locomotion has been greatly increased by the use of artificial neural networks in recent years. The proposed methodology aims at overcoming the constraints of traditional analysi...
متن کاملGait Based Vertical Ground Reaction Force Analysis for Parkinson’s Disease Diagnosis Using Self Organizing Map
The aim of this work is to use Self Organizing Map (SOM) for clustering of locomotion kinetic characteristics in normal and Parkinson’s disease. The classification and analysis of the kinematic characteristics of human locomotion has been greatly increased by the use of artificial neural networks in recent years. The proposed methodology aims at overcoming the constraints of traditional analysi...
متن کامل